Stem Cell and Regenerative Medicine

Janet Downie is the Chief Executive Officer for Roslin Cell Therapies, a leading cell therapy contract manufacturer and process development company based in Edinburgh. She has completed her BSc in Biological Sciences with over 20 years’ experience within the life sciences industry in Scotland with many years’ experience in cell therapy manufacturing and GMP translation. She was previously worked as Chief Operating Officer for Roslin Cells where she spent 8 years setting up and developing the cell therapy division before the Roslin Cell Therapies subsidiary was formed to enable investment and company growth. She is the Human Tissue Authority, Designated Individual and MHRA License Holder for the Roslin Cells GMP Cellular Therapy Facility within the Scottish Centre for Regenerative Medicine. She is a Member of the BIA Manufacturing Advisory Committee and the Research Quality Assurance (RQA) GMP Committee.